A major advance in cancer research is occurring with the use of mini-antibodies to reactivate damaged p53. This crucial malignant suppressor protein is frequently lost in several kinds of malignancies, causing https://mysitesname.com/story11930118/vhh-fragments-revive-the-p53-protein-a-new-pathway-for-cancer-management